Aptiv Solutions and Tessella have formed a collaboration to deliver integrated early phase adaptive design and execution services to the biopharma industry. Aptiv has licensed the use of FACTS, the adaptive trial design software developed by Tessella and Berry Consultants for early phase clinical studies. This, in combination with Aptiv’s ADDPLAN,  adaptive trial design software for late phase confirmatory studies, enables Aptiv to provide a complete range of adaptive design capabilities ...